BVNKF:OTCMKTS
Bavarian Nordic A/S
၃၆.၀၆ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၈, GMT-၄ ၁၅:၄၆:၂၅ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BVNKF...
Mkt. cap
၂၈၂.၈၀ ဋေ
Avg. vol.
၁၄.၀၀
Volume
၀.၀၀
52-wk high
၃၇.၂၂ US$
52-wk low
၂၇.၆၉ US$
Beta
၁.၄၆
Shares outstanding
၇.၉၃ ကုဋေ
No. of employees
၂ ထောင်
Mkt. cap
၂၈၂.၈၀ ဋေ
Avg. vol.
၁၄.၀၀
Volume
၀.၀၀
52-wk high
၃၇.၂၂ US$
52-wk low
၂၇.၆၉ US$
Beta
၁.၄၆
Shares outstanding
၇.၉၃ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Investor's Business Daily
·
ပြီးခဲ့သည့် ၁ နာရီ
Dow Jones Futures: Techs Slide On Anthropic Valuation Doubts; Tesla Roadster On Tap
FinancialContent
·
ပြီးခဲ့သည့် ၅၇ မိနစ်
Kaplan Fox Encourages Qfin Holdings, Inc. (NASDAQ: QFIN) Investors to Contact the Firm Before the Deadline on November 27, 2026
Moomoo
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
Dow Jones Top Company Headlines at 9 PM ET: Netflix Replaces Content Chief as It Struggles to Engage Viewers | Tesla's ...
WSJ
·
ပြီးခဲ့သည့် ၄ နာရီ
Stocks Gain as Treasury Yields Give Back Some Recent Gains
Profile
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
About Bavarian Nordic A/S